| __timestamp | Bausch Health Companies Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 22570000 |
| Thursday, January 1, 2015 | 2682700000 | 24378000 |
| Friday, January 1, 2016 | 2810000000 | 26621000 |
| Sunday, January 1, 2017 | 2582000000 | 28653000 |
| Monday, January 1, 2018 | 2473000000 | 37734000 |
| Tuesday, January 1, 2019 | 2554000000 | 41884000 |
| Wednesday, January 1, 2020 | 2367000000 | 64435000 |
| Friday, January 1, 2021 | 2624000000 | 57483000 |
| Saturday, January 1, 2022 | 2625000000 | 70062000 |
| Sunday, January 1, 2023 | 2917000000 | 52790000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Bausch Health Companies Inc. and Ligand Pharmaceuticals Incorporated from 2014 to 2023. Bausch Health, a major player, consistently reported higher SG&A expenses, peaking at approximately $2.9 billion in 2023, reflecting a 44% increase from 2014. In contrast, Ligand Pharmaceuticals, a smaller entity, saw its SG&A expenses grow by over 130%, reaching around $70 million in 2022. This stark contrast highlights the differing scales and operational strategies of these companies. While Bausch Health's expenses indicate a stable yet expansive approach, Ligand's growth suggests a more dynamic shift in its business model. These insights provide a window into the strategic priorities and market positioning of these pharmaceutical giants.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Bausch Health Companies Inc.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing Biogen Inc. and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing BeiGene, Ltd. and Bausch Health Companies Inc.
Insmed Incorporated or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Ascendis Pharma A/S or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Grifols, S.A. vs Bausch Health Companies Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Ligand Pharmaceuticals Incorporated
Viking Therapeutics, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Bausch Health Companies Inc. or Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Amicus Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated